Mutations Position Table

MAPT P301 Mutations

Tools

Back to the Top
Mutation Pathogenicity DNA Change Expected RNA | Protein Consequence Coding/Non-Coding Genomic Region Neuropathology Biological Effect Primary
Papers
P301P
FTD : Benign Substitution Substitution | Silent Coding Exon 10

Patient had severe neuronal loss in the frontal and temporal cortices, globus pallidus, substantia nigra, red nucleus, and dentate nucleus. Tau-positive fibrillar structures in neurons and glia in these regions. The pathology was attributed to the IVS10+11 mutation in MAPT, which the patient also carried.

No change in the ratio of 3-repeat (3R) to 4-repeat (4R) tau isoforms.

Miyamoto et al., 2001
P301L
FTD : Pathogenic Substitution Substitution | Missense Coding Exon 10

Tau aggregates consisting mainly of 4-repeat (4R) isoforms. Numerous intracytoplasmic tau deposits in neurons and glia in multiple brain regions, including the hippocampus, neocortex, and substantia nigra. Severe neuronal loss, gliosis, and a few ballooned cells in the frontal and temporal cortices.

Strongly promotes β-sheet formation and accelerates the formation of paired helical filament; Does not affect exon 10 splicing.

Hutton et al., 1998;
Dumanchin et al., 1998;
Clark et al., 1998;
Spillantini et al., 1998
P301S
FTD : Pathogenic Substitution Substitution | Missense Coding Exon 10

Frontotemporal atrophy and extensive inclusions of hyperphosphorylated tau in neurons and glia.

Recombinant tau protein with the P301S mutation showed a greatly impaired ability to promote microtubule assembly.

Bugiani et al., 1999;
Sperfeld et al., 1999;
Lossos et al., 2003
P301T
FTD : Pathogenic, CBS : Pathogenic, GGT : Pathogenic Substitution Substitution | Missense Coding Exon 10

Globular deposits composed of four-repeat tau in astrocytes and oligodendrocytes, characteristic of globular glial tauopathy. Neuron loss in frontal cortex, substantia nigra, and spinal cord; spongiosis and astrogliosis in cortex and subcortical regions; neurofibrillary tangles; and demyelination of the corticospinal tracts.

Unknown.

Lladó et al., 2007;
Erro et al., 2019

Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.